Risk behaviors of youth living with HIV: Pre- and post-HAART

American Journal of Health Behavior

Volumn 29, Issue 2, 2005, Pages 162-171

  Lightfoot, Marguerita ^a,b   Swendeman, Dallas ^a   Rotheram Borus, Mary Jane ^a   Comulada, W Scott ^a   Weiss, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

HAART; HIV AIDS; Sexual risk behaviors; Substance use; Youth with HIV

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISTRESS SYNDROME; EMOTION; FEMALE; HEALTH BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MALE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; VIRUS TRANSMISSION;

EID: 14844299784     PISSN: 10873244     EISSN: None     Source Type: Journal    
DOI: 10.5993/ajhb.29.2.7     Document Type: Article

References (42)

1. UNAIDS Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 1998. Available at: http://www.who.int/emc-hiv. Accessed December 4, 2003.
2. Centers for Disease Control and Prevention (CDC). 1999 USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR. 1999;48:1-59.
3. World Health Organization (WHO). Child and adolescent health and development: Adolescents and HIV/AIDS. Available at: http://www.who.int/child- adolescent-health/HIV/HIV_adolescents.htm. Accessed September 23, 2002.
4. Centers for Disease Control and Prevention. Young people risk: HIV/AIDS among America's Youth. Available at http://www.cdc.gov/hiv/pubs/facts/youth.pdf. Accessed November 3, 2003.
5. Rotheram-Borus MJ, Futterman D. Promoting early detection of HIV among adolescents. Arch Pediatr Adolesc Med. 2000;154:435-439.
6. Rotheram-Borus MJ, O'Keefe Z, Kracker R, et al. Prevention of HIV among adolescents. Prev Science. 2000;1:15-30.
7. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. Division of HIV/AIDS and Prevention. Available at http://www.cdc.gov/hiv/stats/ hasrlink.htm. Accessed May 20, 2004.
8. Centers for Disease Control and Prevention. U.S. HIV and AIDS cases reported through June 2001, Midyear edition, Vol. 13, No. 1. Available at http://www.cdc.gov/hiv/stats/hasr1301.htm. Accessed July 23, 2003.
9. Herek GM, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: prevalence and trends, 1991-1999. Am J Public Health. 2002;92(3):371-377.
10. Connor EM, Mofenson LM. Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076 - results and treatment recommendations. Pe diatr Infect Dis J. 1995;14(6):536-541.
11. Frenkel LM, Wagner LE 2nd, Demeter LM, et al. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Cl in Infect Dis. 1995;20(5):1321-1326.
12. Centers for Disease Control and Prevention. Surveillance Report: U.S. HIV and AIDS cases reported through December, 1995 - Year end edition. Vol. 7, No. 2. Available at http://www.cdc.gov/hiv/stats/hivsur72.pdf. Accessed July 12, 2003.
13. Ho DD. Viral counts count in HIV infection. Science. 1996;272:1124-1125.
14. Branson BM, Gayle HD. Home testing for HIV: It's coming. Are you ready? Int AIDS Nwsltr. 1996;4:7-8.
15. Centers for Disease Control and Prevention. Surveillance Report: U.S. HIV and AIDS cases reported through December, 1997 - Year end edition. Vol. 9, No. 2. Available at http://www.cdc.gov/hiv/stats/hivsur92.pdf.
16. Vanable PA, Ostrow DG, McKirnan DJ, et al. Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychol. 2000;19(2):134-145.
17. Dukers NH, Goudsmit J, de Wit JB, et al. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-I infection. AIDS. 2001;15(3):369-378.
18. Boily MC, Bastos FI, Desai K, et al. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models. Sex Transm Dis. 2004;31(2):100-13.
19. Scheer S, Chu PL, Klausner JD, et al. Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet. 2001;357:432-435.
20. Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: A review of social, psychological, and medical findings. AIDS. 2002;16:135-149.
21. Kennedy CA, Skurnick J, Wan JY, et al. Psychological distress, drug and alcohol use as correlates of condom use in HIV-serodiscordant heterosexual couples. AIDS. 1993;7:1493-1499.
22. Kalichman SC, Nachimson D, Cherry C, et al. AIDS treatment advances and behavioral prevention setbacks: preliminary assessment of reduced perceived threat of HIV-AIDS. Health Psychol 1998;17(6):546-550.
23. Kalichman SC, Rompa D, Coley B. Experimental component analysis of a behavioral HIV-AIDS prevention intervention for inner-city women. J Consult Clin Psychol. 1996;64:687-693.
24. Robins AG, Dew MA, Davidson S, et al. Psychosocial factors associated with risky sexual behavior among HIV-seropositive gay men. AIDS Educ Prev. 1994;6(6):483-492.
25. Chow R, Chin T, Fong IW, et al. Medication use patterns in HIV-positive patients. Can J Hosp Pharm. 1993;46:171-175.
26. Bogart LM, Catz SL, Kelly JA, et al. Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making. 2001;21(1):28-36.
27. Rotheram-Borus MJ, Lee M, Zhou S, et al. Variation in health and risk behaviors among youth living with HIV. AIDS Educ Prev. 2001;13:42-54.
28. Murphy DA, Rotheram-Borus MJ, Joshi V. HIV-infected adolescent and adult perceptions of tuberculosis testing, knowledge, and medication adherence in the USA. AIDS Care. 2000;12:59-63.
29. Derogatis LR. Brief Symptom Inventory: Administration, Scoring, and Procedures Manual. Minneapolis, MN: National Computer Systems, Inc., 1993.
30. Namir S, Wolcott DL, Fawzy FI, et al. Coping with AIDS: psychological and health implications. J Appl Social Psychol. 1987;17:309-328.
31. Murphy DA, Rotheram-Borus MJ, Marelich WD. Factor structure of a coping scale across two samples. J Applied Soc Psychol. 2003;3(3):627-647.
32. SAS Inc., Cary, North Carolina, USA.
33. Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for use of antiretroviral agents in HIV-infected adults and adolescents. MMWR. 1998;47:No.RR-5.
34. Rodgers AS, Futterman D, Levin L, et al. A profile of HIV-infected adolescents receiving health care services at selected sites in the United States. J Adolesc Health 1996;19:401-408.
35. HIV/AIDS Bureau. Youth and AIDS. Available at http://hab.hrsa.gov/ programs/factsheets/youthfact.htm. Accessed May 16, 2004.
36. Vlahov D, Safaien M, Lai S, et al. Sexual and drug risk-related behaviors after initiating highly active antiretroviral therapy among injection drug users. AIDS. 2001;15:2311-2316.
37. Suarez TP, Kelly JA, Pinkerton SD, et al. Influence of a partner's HIV serostatus, use of highly active antiretroviral therapy, and viral load on perceptions of sexual risk behavior in a community sample of men who have sex with men. J Acquir Immune Defic Syndr. 2001;28(5):471-477.
38. Ostrow DE, Fox KJ, Chmiel JS, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AID S. 2002;16(5):775-780.
39. Sontag D, Richardson L. Doctors withhold HIV pill regimen from some; failure to follow rigid schedule could hurt others, they fear (human immunodeficiency virus; treatment complicated by ability of patients stay on schedule). New York Times, 1997;146, sec1:1(N), 1(L), col 3.
40. Chow R, Chin T, Fong IW, et al. Medication use patterns in HIV-positive patients. Can J Hosp Pharm 1993;46:171-175.
41. Becker SL, Dezii CM, Burtcel B, et al. Young HIV-infected adults are at greater risk for medication non-adherence. Medscape General Medicine, 4. Available at www.medscape.com/viewarticle/438510.
42. Murphy DA, Wilson CM, Durako SJ, et al. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13:27-40.